These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 10975310

  • 21. The expanding spectrum of renal diseases associated with antiphospholipid syndrome.
    Fakhouri F, Noël LH, Zuber J, Beaufils H, Martinez F, Lebon P, Papo T, Chauveau D, Bletry O, Grünfeld JP, Piette JC, Lesavre P.
    Am J Kidney Dis; 2003 Jun; 41(6):1205-11. PubMed ID: 12776272
    [Abstract] [Full Text] [Related]

  • 22. Clinical outcomes in patients with biopsy-proved diabetic nephropathy compared to isolated lupus or crescentic glomerulonephritis.
    Chou YH, Lin WC, Chen YM.
    Diabetes Res Clin Pract; 2019 Feb; 148():144-151. PubMed ID: 30641169
    [Abstract] [Full Text] [Related]

  • 23. Non-lupus full house nephropathy in pediatrics: Case reports.
    Guerrero GA, Guerrero LF, González T.
    Biomedica; 2020 Jun 15; 40(2):220-227. PubMed ID: 32673451
    [Abstract] [Full Text] [Related]

  • 24. Hypocomplementemic urticarial vasculitis syndrome with gastrointestinal vasculitis and crescentic membranoproliferative glomerulonephritis without immune complex deposits.
    Ueki K, Tsuchimoto A, Matsukuma Y, Torisu K, Fujisaki K, Torisu T, Yamada Y, Oda Y, Masutani K, Nakano T, Tsuruya K, Kitazono T.
    CEN Case Rep; 2020 Feb 15; 9(1):30-35. PubMed ID: 31586313
    [Abstract] [Full Text] [Related]

  • 25. C1q nephropathy in a 2-year-old boy presenting with steroid resistant nephrotic syndrome.
    Niimura F, Kamei A, Tamame T, Yamada K, Komaki F, Okamoto S, Matsuda S, Oh Y, Endoh M.
    Tokai J Exp Clin Med; 2007 Sep 20; 32(3):95-8. PubMed ID: 21318945
    [Abstract] [Full Text] [Related]

  • 26. [Retrospective study of primary IgA nephropathy with crescent formation and/or rapidly progressive glomerulonephritis in children].
    Wang D, Wang F, Ding J, Xiao H, Zhong X, Liu X.
    Zhonghua Er Ke Za Zhi; 2015 Sep 20; 53(9):670-5. PubMed ID: 26757967
    [Abstract] [Full Text] [Related]

  • 27. [Advances in clinical research on C1q nephropathy].
    Yang J, Zhang BL.
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 Nov 20; 18(11):1194-1198. PubMed ID: 27817791
    [Abstract] [Full Text] [Related]

  • 28. Crescentic glomerulonephritis developing in the course of idiopathic membranoproliferative glomerulonephritis.
    Sharma A, Gupta R, Lal C, Agarwal SK, Dinda AK.
    Saudi J Kidney Dis Transpl; 2013 Mar 20; 24(2):333-7. PubMed ID: 23538361
    [Abstract] [Full Text] [Related]

  • 29. Pauci-immune necrotizing and crescentic glomerulonephritis in a patient with systemic lupus erythematosus.
    Fayaz A, Pirson Y, Cosyns JP, Yango J, Lambert M.
    Clin Nephrol; 2008 Apr 20; 69(4):290-3. PubMed ID: 18397704
    [Abstract] [Full Text] [Related]

  • 30. [C1Q NEPHROPATHY: CASE REPORTS AND LITERATURE REVIEW].
    Galešić K, Horvatić I, Batinić D, Milošević D, Saraga M, Durdov MG, Ljubanović DG.
    Lijec Vjesn; 2015 Apr 20; 137(9-10):283-7. PubMed ID: 26749950
    [Abstract] [Full Text] [Related]

  • 31. C1q Nephropathy: The Unique Underrecognized Pathological Entity.
    Devasahayam J, Erode-Singaravelu G, Bhat Z, Oliver T, Chandran A, Zeng X, Dakshinesh P, Pillai U.
    Anal Cell Pathol (Amst); 2015 Apr 20; 2015():490413. PubMed ID: 26640759
    [Abstract] [Full Text] [Related]

  • 32. Rapidly Progressive Glomerulonephritis Secondary to IgA Nephropathy in a Patient with Systemic Lupus Erythematosus.
    Patel AM, Karam LAR, Rojas SCF, Redfearn WE, Truong LD, Gonzalez JM.
    Case Rep Nephrol; 2019 Apr 20; 2019():8354823. PubMed ID: 30956828
    [Abstract] [Full Text] [Related]

  • 33. IgG nephropathy - confusion and overlap with C1q nephropathy.
    Lim BJ, Hong SW, Jeong HJ.
    Clin Nephrol; 2009 Nov 20; 72(5):360-5. PubMed ID: 19863878
    [Abstract] [Full Text] [Related]

  • 34. Distinguishing C1q nephropathy from lupus nephritis.
    Sharman A, Furness P, Feehally J.
    Nephrol Dial Transplant; 2004 Jun 20; 19(6):1420-6. PubMed ID: 15004260
    [Abstract] [Full Text] [Related]

  • 35. C1q nephropathy with acute hemolytic uremic syndrome.
    Kanodia KV, Vanikar AV, Shah PR, Kute VB, Feroz A, Suthar K, Trivedi HL.
    Saudi J Kidney Dis Transpl; 2012 May 20; 23(3):556-8. PubMed ID: 22569444
    [Abstract] [Full Text] [Related]

  • 36. Resolution of clinical and pathologic features of C1q nephropathy after rituximab therapy.
    Sinha A, Nast CC, Hristea I, Vo AA, Jordan SC.
    Clin Exp Nephrol; 2011 Feb 20; 15(1):164-70. PubMed ID: 21107633
    [Abstract] [Full Text] [Related]

  • 37. Occurrence of anti-C1q antibodies in IgA nephropathy.
    Gunnarsson I, Rönnelid J, Lundberg I, Jacobson SH.
    Nephrol Dial Transplant; 1997 Nov 20; 12(11):2263-8. PubMed ID: 9394309
    [Abstract] [Full Text] [Related]

  • 38. Biopsy-proven kidney involvement in hypocomplementemic urticarial vasculitis.
    Corthier A, Jachiet M, Bertin D, Servais A, Barbet C, Bigot A, Doutre MS, Bessis D, Bouffandeau A, Moranne O, Jarrot PA, Bardin N, Terrier B, Burtey S, Puéchal X, Daniel L, Jourde-Chiche N.
    BMC Nephrol; 2022 Feb 16; 23(1):67. PubMed ID: 35172758
    [Abstract] [Full Text] [Related]

  • 39. C1q nephropathy in a patient complicated with nephrotic syndrome and refractory to steroid therapy.
    Yang YH, Lee WS, Cheng CY.
    J Microbiol Immunol Infect; 2020 Feb 16; 53(1):183-185. PubMed ID: 31288973
    [No Abstract] [Full Text] [Related]

  • 40. ANCA positive crescentic glomerulonephritis outcome in a Central East European cohort: a retrospective study.
    Andreiana I, Stancu S, Avram A, Taran L, Mircescu G.
    BMC Nephrol; 2015 Jun 30; 16():90. PubMed ID: 26123651
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.